JMC | Insilico Medicine presents the discovery of the potent and selective MYT1 inhibitors for the treatment of cancer through generative AI
Insilico Medicine(“Insilico”), a clinical stage generative artificial intelligence (AI)-driven drug discovery company, recently published an early research that it has ...